Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 925 of 3173 entries
View as:

A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04090047 Org: User:
Start: 09/24/19 End: 12/19/19 Due: 12/19/20

A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Phase: N/A Priority: Normal
NCT ID: NCT01646398 Org: User:
Start: 06/30/12 End: 10/31/12 Due: 10/31/13

Non-Interventional Study To Investigate Whether Information Provided To Patients Influences Their Satisfaction With Toviaz Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01091519 Org: User:
Start: 12/31/10 End: 05/31/12 Due: 05/31/13

A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01200394 Org: User:
Start: 12/31/10 End: 08/31/13 Due: 08/31/14

For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00037180 Org: User:
Start: 04/30/02 End: 01/31/03 Due: 01/31/04

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01336738 Org: User:
Start: 06/30/11 End: 03/31/12 Due: 03/31/13

A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01470599 Org: User:
Start: 04/30/12 End: 07/31/16 Due: 07/31/17

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

Phase: N/A Priority: Normal
NCT ID: NCT02684006 Org: User:
Start: 03/23/16 End: 06/26/24 Due: 06/26/25

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00678392 Org: User:
Start: 09/03/08 End: 02/25/16 Due: 02/25/17

A Phase 2/3 Study in Adult and Pediatric Participants With SCD

Phase: N/A Priority: Normal
NCT ID: NCT05431088 Org: User:
Start: 09/22/22 End: 12/30/32 Due: 12/30/33

A Study To Determine Any Effect Of Tafamidis On Electrocardiographic Intervals, Specifically The Rate Corrected QT Interval (QTc)

Phase: N/A Priority: Normal
NCT ID: NCT01775761 Org: User:
Start: 01/31/13 End: 04/30/13 Due: 04/30/14

Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00690378 Org: User:
Start: 11/30/08 End: 07/31/10 Due: 07/31/11

Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

Phase: N/A Priority: Normal
NCT ID: NCT04744454 Org: User:
Start: 10/28/21 End: 01/30/26 Due: 01/30/27

PF-07104091 as a Single Agent and in Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04553133 Org: User:
Start: 09/16/20 End: 03/30/26 Due: 03/30/27

Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology

Phase: N/A Priority: Normal
NCT ID: NCT00596830 Org: User:
Start: 04/30/08 End: 09/30/12 Due: 09/30/13

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00106353 Org: User:
Start: 03/31/05 End: 01/31/12 Due: 01/31/13

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Phase: N/A Priority: Normal
NCT ID: NCT00372775 Org: User:
Start: 03/31/07 End: 12/31/09 Due: 12/31/10

A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162

Phase: N/A Priority: Normal
NCT ID: NCT01691274 Org: User:
Start: 10/31/12 End: 03/31/13 Due: 03/31/14

Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00914641 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05580003 Org: User:
Start: 10/17/22 End: 09/15/23 Due: 09/15/24

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00565409 Org: User:
Start: 03/31/08 End: 05/31/11 Due: 05/31/12

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06966453 Org: User:
Start: 06/30/25 End: 08/29/29 Due: 08/29/30

A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Phase: N/A Priority: Normal
NCT ID: NCT03289533 Org: User:
Start: 09/08/17 End: 10/25/19 Due: 10/25/20

A Study of UK-369,003 on the Safety and Efficacy in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT00163098 Org: User:
Start: 12/31/04 End: 12/31/05 Due: 12/31/06

An Open-Label, Single Dose Pharmacokinetic Study of Benefix (Recombinant Factor IX) in Male Chinese Subjects With Hemophilia B

Phase: N/A Priority: Normal
NCT ID: NCT02213250 Org: User:
Start: 03/31/15 End: 04/30/15 Due: 04/30/16